Paired box 9 (PAX9) is a transcription factor of the PAX family functioning as both a transcriptional activator and a repressor. At this stage it has been demonstrated that the PAX9 gene is a key gene in embryonic development, but its function in a variety of cancers is still unknown. PAX9 was found to be overexpressed in lung adenocarcinoma (LUAD) samples according to the TCGA database on the Bioinformatics website. At the same time, it was found that PAX9 expression was higher in lung cancer cell lines compared to normal lung epithelial cell lines by qRT-PCR and Western Blot. To investigate the role of PAX9 in LUAD, an A549 cell line with stable knockdown of PAX9 was constructed. It was demonstrated by EdU assay that PAX9 could promote the proliferation of A549 cells by promoting cell cycle changes. In parallel, wound healing assay and transwell assay were performed, and the results showed that knockdown of PAX9 significantly inhibited the migration and invasion ability of A549 cell line. Our results showed that in A549 cell lines, the higher expression of PAX9, the higher ability of proliferation, migration and invasion. Our study may provide new therapeutic ideas for the future treatment of LUAD.
A publicly accessible online database was utilized in this study to investigate COMP, which is aberrantly expressed in a range of malignancies. It was discovered that colorectal cancer had significant levels of COMP expression. This finding was corroborated by Western Blot and RT-qPCR analysis tests on colorectal cancer cell lines. In order to study the effect of COMP on colorectal cancer migration, we investigated the expression of mRNA and protein levels in colorectal cancer cell lines knocked down by COMP, and the effect of COMP on the migration of SW480 cell line was studied using Transwell, wound healing assay. The findings demonstrated that the migration of colorectal cancer cell lines was suppressed by COMP expression knockdown. These findings offer a theoretical foundation for the use of COMP as a novel clinical treatment target and possible marker for the identification of colorectal cancer metastases.